Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA accepts DigiTAb filing for review

Oct. 15, 1999

Schein to license proprietary chelating compound from SunPharm

Oct. 8, 1999

Carbamazepine for the prevention and treatment of alcohol withdrawal syndrome

Sep. 28, 1999

NIDA study sheds new insight on cocaine addiction process

Sep. 23, 1999

Nalmefene reduces relapse to heavy drinking

Sep. 22, 1999

MedImmune licenses catalytic antibody against cocaine

Sep. 17, 1999

Sublingual nicotine tablets as alternative to Nicorette gum: clinical results reported at FIP '99

Sep. 8, 1999

Ferriprox approved in Europe as second-line thalassemia therapy

Aug. 27, 1999

Advances in the immunotherapy of cocaine abuse at Scripps Research Institute

Aug. 26, 1999

Academic researchers identify MAb as effective treatment for PCP addiction

Aug. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...